User profiles for Lukasz Woz´niacki

Łukasz Woźniacki

Instytut Matki i Dziecka w Warszawie
Verified email at imid.med.pl
Cited by 128

[HTML][HTML] Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

L Naehrlich, A Orenti, F Dunlevy, I Kasmi… - Journal of cystic …, 2021 - Elsevier
… Woźniacki Łukasz: Resources, Writing - Review & Editing. Pereira Luísa: Resources, Writing
Wozniacki has nothing to disclose; Dr. Pereira has nothing to disclose; Dr. Pop has nothing …

[HTML][HTML] Clinical complications in children with false-negative results in cystic fibrosis newborn screening

K Zybert, U Borawska-Kowalczyk, L Wozniacki… - Jornal de …, 2022 - SciELO Brasil
Objective: To present signs and symptoms and clinical course in cystic fibrosis patients with
false-negative newborn screening (CF NBS). Materials and methods: All children presented …

Clinical characteristics of rare CFTR mutations causing cystic fibrosis in Polish population

K Zybert, L Wozniacki… - Pediatric …, 2020 - Wiley Online Library
Introduction More than 2000 mutations have been identified since the discovery of the
CFTR gene in 1989. However, only 346 mutations have been classified as cystic fibrosis (CF)‐…

[HTML][HTML] Renal amyloidosis in Whipple disease: a case report

S Niemczyk, E Filipowicz, L Wozniacki, J Grochowski… - Cases Journal, 2009 - Springer
Introduction Whipple disease is a rare systemic infection caused by Tropheryma whippelii
that usually manifests with joint pain, weight loss, diarrhoea and abdominal pain. However, in …

[PDF][PDF] Guidance To Foster Green Public Procurement

L Wozniacki - European Environmental Bureau, 2012 - koinno-bmwk.de
We are living in the age of sustainable development. Every respected private company is
trying to show that they are doing something in this regard. In the most cases, private …

Determining the enzymatic activities of iodothyronine 5'-deiodinases in renal medulla and cortex

S Niemczyk, M Dudek, Z Bartoszewicz… - Endokrynologia …, 2013 - journals.viamedica.pl
Introduction: Thyroid hormone disorders in patients with chronic kidney disease (CKD) are a
result of impaired conversion of T4 to T3. The importance of kidneys in thyroid hormones …

Availability of CFTR modulators in countries of Eastern Europe: the reality in 2022

…, K Stepankova, L Wozniacki… - Journal of Cystic …, 2022 - cysticfibrosisjournal.com
The 3rd V4 (ie, Visegrad) international cystic fibrosis (CF) conference, held in November
2021 in Krakow, provided the opportunity to compare the availability of CFTR modulator (…

[HTML][HTML] Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe

…, M Schlesser, V Storms, O Turcu, L Woz… - ERJ open …, 2021 - Eur Respiratory Soc
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
people with cystic fibrosis (pwCF) can lead to severe outcomes. Methods In this observational …

[HTML][HTML] Share this story: RELATED ARTICLES

S Niemczyk, Ł Wozniacki - hospitalpharmacyeurope.com
Erythropoietin deficiency is the main cause of anaemia in patients with chronic kidney
disease (CKD). This common and debilitating condition is associated with cardiovascular …

[HTML][HTML] Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing …

…, CLU Anna-Maria, ZNL Domenique, WPL Lukasz… - Journal of Cystic …, 2024 - Elsevier
Background Lumacaftor/ivacaftor (LUM/IVA) has been shown to be safe and efficacious in
people with cystic fibrosis (CF) ≥1 year of age. To assess the impact of early LUM/IVA …